Trials / Terminated
TerminatedNCT00325455
MK0859 Dose-Ranging Study (0859-003)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of MK-0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To assess the cholesterol changing effects of MK0859 in patients with primary hypercholesterolemia or mixed dyslipidemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0859 |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2007-02-01
- Completion
- 2007-03-01
- First posted
- 2006-05-12
- Last updated
- 2015-03-02
Source: ClinicalTrials.gov record NCT00325455. Inclusion in this directory is not an endorsement.